Literature DB >> 20855744

In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.

Manuela Donati1, Antonietta Di Francesco, Antonietta D'Antuono, Federica Delucca, Alisa Shurdhi, Alessandra Moroni, Raffaella Baldelli, Roberto Cevenini.   

Abstract

A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to antimicrobial agents.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20855744      PMCID： PMC2981272          DOI： 10.1128/AAC.00553-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Clinical practice. Genital chlamydial infections.

Authors:  Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

2.  In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  L E Welsh; C A Gaydos; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.

Authors:  Patricia M Roblin; Stephan A Kohlhoff; Charles Parker; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

4.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

Review 5.  Treatment of Chlamydia trachomatis genital infection.

Authors:  K E Toomey; R C Barnes
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

6.  Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.

Authors:  M Donati; M Rodrìguez Fermepin; A Olmo; L D'Apote; R Cevenini
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

Review 7.  Update on Chlamydia trachomatis.

Authors:  S Guaschino; F De Seta
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

8.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 9.  Treatment of uncomplicated genital Chlamydia trachomatis infections in adults.

Authors:  Adaora A Adimora
Journal:  Clin Infect Dis       Date:  2002-10-15       Impact factor: 9.079

10.  Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.

Authors:  R J Rice; V Bhullar; S H Mitchell; J Bullard; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191
View more
  7 in total

1.  In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.

Authors:  Suncanica Ljubin-Sternak; Tomislav Mestrovic; Tatjana Vilibic-Cavlek; Gordana Mlinaric-Galinovic; Mario Sviben; Alemka Markotic; Visnja Skerk
Journal:  Folia Microbiol (Praha)       Date:  2012-12-29       Impact factor: 2.099

Review 2.  Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health.

Authors:  Sunčanica Ljubin-Sternak; Tomislav Meštrović
Journal:  J Pathog       Date:  2014-12-31

3.  Tetracycline Susceptibility in Chlamydia suis Pig Isolates.

Authors:  Manuela Donati; Andrea Balboni; Karine Laroucau; Rachid Aaziz; Fabien Vorimore; Nicole Borel; Federico Morandi; Edoardo Vecchio Nepita; Antonietta Di Francesco
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

4.  Selective Pressure Promotes Tetracycline Resistance of Chlamydia Suis in Fattening Pigs.

Authors:  Sabrina Wanninger; Manuela Donati; Antonietta Di Francesco; Michael Hässig; Karolin Hoffmann; Helena M B Seth-Smith; Hanna Marti; Nicole Borel
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 5.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

6.  Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin.

Authors:  Eveline Staub; Hanna Marti; Roberta Biondi; Aurora Levi; Manuela Donati; Cory Ann Leonard; Serej D Ley; Trestan Pillonel; Gilbert Greub; Helena M B Seth-Smith; Nicole Borel
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.996

7.  Evaluating the Antibiotic Susceptibility of Chlamydia - New Approaches for in Vitro Assays.

Authors:  Hanna Marti; Nicole Borel; Deborah Dean; Cory A Leonard
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.